Characterizing the interruption-recovery patterns of urban air pollution under the COVID-19 lockdown in China.
Build Environ
; 205: 108231, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1454046
ABSTRACT
The COVID-19 pandemic provides an opportunity to study the effects of urban lockdown policies on the variation in pollutant concentrations and to characterize the recovery patterns of urban air pollution under the interruption of COVID-19 lockdown policies. In this paper, interruption-recovery models and regression discontinuity design were developed to characterize air pollution interruption-recovery patterns and analyze environmental impacts of the COVID-19 lockdown, using air pollution data from four Chinese metropolises (i.e., Shanghai, Wuhan, Tianjin, and Guangzhou). The results revealed the air pollutant interruption-recovery curve represented by the three lockdown response periods (Level I, Level II and Level III) during COVID-19. The curve decreased during Level I (A 25.3%-48.8% drop in the concentration of NO2 has been observed in the four metropolises compared with the same period in 2018-2019.), then recovered around reopening, but decreased again during Level III. Moreover, the interruption-recovery curve of the year-on-year air pollution difference suggests a process of first decreasing during Level I and gradually recovering to a new equilibrium during Level III (e.g., the unit cumulative difference of NO2 mass concentrations in Shanghai was 21.7, 22.5, 11.3 (µg/m3) during Level I, II, and III and other metropolises shared similar results). Our findings reveal general trends in the air quality externality of different lockdown policies, hence could provide valuable insights into air pollutant interruption-recovery patterns and clear scientific guides for policymakers to estimate the effect of different lockdown policies on urban air quality.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
Build Environ
Year:
2021
Document Type:
Article
Affiliation country:
J.buildenv.2021.108231
Similar
MEDLINE
...
LILACS
LIS